Hamill Life Sciences is the advisory practice of Stefan Hamill, helping to transform exceptional science into exceptional companies.
Stef is a PhD scientist, exited founder, investor and former top-ranked life sciences analyst, working with ambitious companies and investors on strategy, capital raising and growth.
Hamill Life Sciences helps companies make better decisions, tell a stronger story, win in the battle for capital and build more valuable businesses.
We typically work with founders, boards and investors in venture-backed technology spinouts and growth-stage companies, in the UK and internationally.
Support can be provided as a fractional executive, board member or strategic adviser, with a strong preference for equity-aligned partnership.
Embedded leadership: part-time, in-seat: for teams that need senior experience now.
Adviser, NED or observer: strategy, capital markets and pattern-matching from prior builds.
Hands-on support on strategy, operations and fundraising: for defined pieces of work.
Advisory services to capital allocators to drive long-term outperformance.
Founders spend every day inside one company. We've spent more than two decades studying hundreds.
Learn from experience of hundreds of life science companies.
Focus on the decisions that will have the greatest impact on long-term value creation.
Tell a stronger story to investors, partners and boards.
Transform exceptional science into valuable and enduring businesses.
Twenty years analysing, advising and building life science companies, most of them before anyone else had heard of them.
"Stef is a specialist in identifying early-stage healthtech companies and supporting management teams to deliver multi-billion-dollar success"
"We are very excited to have Stef join us, especially since we are now entering the commercialisation phase"
If you're building an ambitious life science company and an experienced partner could accelerate the journey, please get in touch.
